The scientific foundation of AGE measurement

Diagnoptics pioneered non-invasive AGE measurement more than 20 years ago. Today, hundreds of studies confirm its reliability and clinical value. Our technology is not only innovative but also evidence-based trusted by universities, hospitals and researchers worldwide.

AGEs & health

Backed by peer-reviewed research

Over the past two decades, AGE measurement has been featured in hundreds of peer-reviewed publications. These studies demonstrate its relevance across diabetes, cardiovascular disease, kidney disease, and aging research.

Our solutions

Proven reliable in clinical practice

Multiple validation studies confirm that AGE-measurement deliver reproducible results and show strong correlation with AGE levels measured in tissue biopsies. Multicenter studies further underline their predictive power for outcomes and complications.

AGE Reader

Clinically validated across regions and conditions

The AGE Reader has been validated in multiple
independent studies, conﬁrming its reliability and
reproducibility in clinical practice.

Validated in >350 clinical studies
Consistent results across independent research groups
Strong correlation with established biomarkers (HbA1c
and CVD markers)
Proven predictive value for prevalence of multiple
chronic diseases.

AGE measurement in practice

Clinical case studies and applications

Prognosis for kidney transplant

The patient is a 56-year old male patient with a kidney transplant. What is the prognosis?

CVD assessment in DM2 patient

The studied patient is a man, 56 years old, with type 2 diabetes, former smoker, with low lipid levels with a statin, and, till now, no complications. How should his cardiovascular risk be considered?

Intensify treatment for DM2?

The patient is a woman, 60 years old, with type 2 diabetes and hypertension, but so far no history of diabetic complications. You consider whether or not to intensify treatment.

Strategic partnerships

Collaboration drives progress

We work closely with leading universities, hospitals and research institutes worldwide. These partnerships validate our technology, expand applications, and ensure that AGE measurement continues to advance clinical and practical use.